You are here

Allergan

Allergan, Gedeon Richter plan depression submission

BioPharma Dive

Tue, 12/19/17 - 10:21 pm

clinical depression

acute bipolar depression

8 Takeout targets to watch in 2018

BioPharma Dive

Sat, 12/16/17 - 08:41 am

Bristol-Myers Squibb

Madrigal Pharmaceuticals

Spark Therapeutics

[forum discussion]A bad move by Allergan

Cafepharma Message Boards

Wed, 12/13/17 - 09:50 am

Allergan buys an ailing Repros, bagging a women’s health drug for the pipeline

Endpoints

Tue, 12/12/17 - 11:18 am

Settle down, Allergan investors. Botox's market share is safe, analysts say

Fierce Pharma

Wed, 12/6/17 - 11:11 am

wrinkle treatment

Watch out Allergan: Revance’s wrinkle-reducer beats Botox in PhIII trials

Endpoints

Tue, 12/5/17 - 09:31 am

clinical trials

wrinkle treatments

EMA investigates Allergan blockbuster hopeful Esmya on reports of liver damage

Fierce Pharma

Mon, 12/4/17 - 09:32 pm

uterine fibroids

Regeneron CEO Schleifer, a year after public Pfizer spat, slams Allergan for tribal deal

Fierce Pharma

Fri, 12/1/17 - 12:39 pm

Leonard Schleifer

Restasis buyers level antitrust lawsuit against Allergan

Drug Delivery Business News

Tue, 11/21/17 - 10:38 pm

Allergan could sell women's health for $6B, if it would only agree to split: analyst

Fierce Pharma

Tue, 11/21/17 - 11:46 am

[forum discussion] Allergan employees discuss impending cost cuts announced by CEO Saunders

Cafepharma Message Boards

Sun, 11/12/17 - 10:34 am

Senators blast Allergan's tribal deal, social contract as 'hypocrisy'

Fierce Pharma

Thu, 11/9/17 - 10:08 am

Allergan executives named in investor suit over alleged generics price fixing

Fierce Pharma

Tue, 11/7/17 - 09:57 pm

Did Allergan lose its $2.1B Kythera bet, or can chin-fat drug Kybella make its mark?

Fierce Pharma

Tue, 11/7/17 - 10:56 am

Allergan CEO Saunders claims 'tenacity' led company into tribal licensing deal

Fierce Pharma

Sun, 11/5/17 - 09:37 am

Where could Allergan’s cost cuts fall? DTC spending, for starters

Fierce Pharma

Thu, 11/2/17 - 10:22 pm

DTC advertising

Allergan draws up battle plans as Restasis, other drugs face patent expiries

BioPharma Dive

Thu, 11/2/17 - 09:30 am

How Allergan plc Lost $4 Billion in Q3 and Still Performed Quite Well

Motley Fool

Wed, 11/1/17 - 06:49 pm

Cost cuts are coming for Allergan, CEO says. But a breakup isn’t

Fierce Pharma

Wed, 11/1/17 - 06:36 pm

Analyst backing an Allergan breakup is undeterred by doubters. Here's why

Fierce Pharma

Mon, 10/30/17 - 02:57 pm

Pages